STUDIES OF THE MECHANISMS INVOLVED IN THE FATE OF PROSTACYCLIN (PGI2) AND 6-KETO-PGF 1-ALPHA IN THE PULMONARY CIRCULATION

被引：57
作者：
HAWKINS, HJ
SMITH, JB
NICOLAOU, KC
ELING, TE
机构：
[1] THOMAS JEFFERSON UNIV,CARDEZA FDN,PHILADELPHIA,PA 19107
[2] UNIV PENN,DEPT CHEM,PHILADELPHIA,PA 19104
来源：
PROSTAGLANDINS | 1978年 / 16卷 / 06期
关键词：
D O I：
10.1016/0090-6980(78)90103-X
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：871 / 884
页数：14
相关论文
共 50 条
[21]   NK1 RECEPTORS MEDIATED RELEASE OF 6-KETO-PGF(1-ALPHA) FROM THE EX-VIVO PERFUSED CANINE ILEUM [J].
PARRISH, MB ;
RAINSFORD, KD ;
JOHNSON, DM ;
DANIEL, EE .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1994, 271 (01) :39-47
[22]   PRODUCTION-RATES OF PROSTAGLANDIN-F, 6-KETO-PGF 1-ALPHA AND THROMBOXANE-B2 BY PERIFUSED HUMAN-ENDOMETRIUM [J].
LIGGINS, GC ;
CAMPOS, GA ;
ROBERTS, CM ;
SKINNER, SJ .
PROSTAGLANDINS & OTHER LIPID MEDIATORS, 1980, 19 (03) :461-477
[23]   6-KETO-PROSTAGLANDIN-E1 IS NOT EQUIPOTENT TO PROSTACYCLIN (PGI2) AS AN ANTI-AGGREGATORY AGENT [J].
MILLER, OV ;
AIKEN, JW ;
SHEBUSKI, RJ ;
GORMAN, RR .
PROSTAGLANDINS, 1980, 20 (02) :391-400
[24]   URINARY 6-KETO-PGF1-ALPHA AFTER CAPTOPRIL AND INDOMETHACIN - POSSIBLE CONTRIBUTION OF PGI2 TO THE ANTIHYPERTENSIVE MECHANISM OF ACE INHIBITORS [J].
MINUZ, P ;
DEGAN, M ;
COVI, G ;
LECHI, C ;
VELO, GP ;
LECHI, A .
ADVANCES IN PROSTAGLANDIN THROMBOXANE AND LEUKOTRIENE RESEARCH, 1985, 13 :199-202
[25]   COMPARISON OF THE PULMONARY, HEPATIC AND RENAL EXTRACTION OF PGI2 AND 6-KETO-PGE1 [J].
TSUNODA, S ;
JACKSON, EK ;
BRANCH, RA ;
GERKENS, JF .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1982, 77 (2-3) :147-151
[26]   Effects of thiofedrine on platelet aggregation, thromboxane B-2 and 6-keto-PGF(1 alpha) in rats [J].
Qu, YZ ;
Wang, YE ;
Li, XX .
METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY, 1996, 18 (05) :297-300
[27]   METABOLISM OF PROSTACYCLIN AND 6-KETO-PROSTAGLANDIN-F 1-ALPHA IN MAN [J].
ROSENKRANZ, B ;
FISCHER, C ;
REIMANN, I ;
WEIMER, KE ;
BECK, G ;
FROLICH, JC .
ARTERY, 1980, 8 (01) :18-22
[28]   LC/MS/MS assay development and validation for 6-keto PGF1α, a metabolite of PGI2 [J].
Chappell, D. L. ;
Radziszewski, W. ;
Tanaka, W. K. ;
Laterza, O. F. .
CLINICAL CHEMISTRY, 2008, 54 (06) :A210-A210
[29]   ANTISERUM AGAINST 9-DEOXY-6,9-EPOXY-PGF1-ALPHA RECOGNIZES AND BINDS PGI2 (PROSTACYCLIN) [J].
FITZPATRICK, FA ;
GORMAN, RR .
PROSTAGLANDINS & OTHER LIPID MEDIATORS, 1978, 15 (04) :725-735
[30]   THE ERYTHROPOIETIC EFFECTS OF 6-KETO-PGE1 AND PGI2 [J].
NELSON, PK ;
FISHER, JW .
CLINICAL RESEARCH, 1981, 29 (05) :A829-A829
12345